Shareholder Alert: Acquisition of Zoll Medical Investigated by Tripp Levy PLLC on behalf of Shareholders
NEW YORK, March 12, 2012 /PRNewswire/ -- Tripp Levy PLLC, a leading national securities law firm, notifies investors of Zoll Medical Corp.(NASDAQ GS:ZOLL) of potential claims of breaches of fiduciary duty and other violations of state law against the board of directors of Zoll in connection with the sale of the company to Asahi Kasei Corporation. It was announced today that Asahi has entered into an agreement to acquire all of the outstanding common stock of Zoll through a cash tender offer for approx. $2.21 billion. Under the terms of the definitive agreement, Asahi intends to commence a tender offer for all of the outstanding shares of common stock of Zoll for $93 per share. The investigation concerns whether the Zoll Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the company before entering into this transaction and whether Asahi is underpaying for Zoll’s shares, thus unlawfully harming stockholders. Indeed, analysts project that the true value of Zoll is at least $100 per share.
If you own Zoll’s common stock and you wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact
Tripp Levy Tripp Levy PLLC 125 East 82nd Street 9th Floor New York, New York Toll Free: 877-772-3975 Email: firstname.lastname@example.org
Tripp Levy PLLC is a national law firm that specializes in mergers & acquisitions, takeover litigation, shareholder rights, and corporate governance matters in state and federal courts throughout the United States. Attorney advertising. Prior results do not guarantee a similar outcome. SOURCE Tripp Levy PLLC